Research output per year
Research output per year
Personal profile
Biography
John Radford is Professor of Medical Oncology at the University of Manchester and Director of Research at the Christie NHS Foundation Trust, both partners in the Manchester Cancer Research Centre (MCRC). His research interests are focused on developing and testing new ways of treating lymphoma and monitoring the effectiveness of these using novel biomarkers. He is also interested in studying the late effects of chemotherapy on fertility, heart function and the risk of second cancers.
John chairs the Manchester Lymphoma Group, is immediate past chair of the UK National Cancer Research Institute (NCRI) Lymphoma Clinical Studies Group and is chief investigator for several national/international trials. He has advised the Parliamentary Ombudsman, NICE and the National Horizon Scanning Centre and is a member of the Editorial Board of the Journal of Clinical Oncology. He became honorary President of Lymphoma Action in September 2019.
Qualifications
- - MB ChB, MD, FRCP, FMedSci
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
FRCP
Award Date: 1 Jun 1997
Doctor of Medicine, Aspects of the Biological Effects of MVPP Chemotherapy for Hodgkin's Disease, The University of Sheffield
Award Date: 1 Oct 1992
Bachelor of Medicine, MB ChB, The University of Sheffield
Award Date: 30 Jun 1978
External positions
Chairman of NCRI Lymphoma Clinical Studies Group, National Cancer Research Institute (NCRI)
Director of Research: The Christie Hospital NHS Foundation Trust
Research Beacons, Institutes and Platforms
- Cancer
- Digital Futures
- Manchester Cancer Research Centre
Keywords
- Cancer
- Lymphoma
- Immunology
Fingerprint
Dive into the research topics where John Radford is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Phillips, E. H., Counsell, N., Illidge, T. M., André, M., Aurer, I., Fiaccadori, V., Fortpied, C., Neven, A., Federico, M., Barrington, S. F., Raemaekers, J. M. & Radford, J., 7 Jan 2025, (E-pub ahead of print) In: Blood Advances.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial
Hamadani, M., Spira, A. I., Zhou, X., Liao, L., Chen, L., Radford, J., Ai, W. Z., Solh, M. M., Ardeshna, K. M., Hess, B. T., Caimi, P. F., Stathis, A., Carlo Stella, C., Alderuccio, J. P., Kahl, B. S., Wang, Y., Qin, Y. G., Xu, Z. C. & Zinzani, P. L., 9 Jan 2024, In: Blood Advances. 8, 1, p. 93-98 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers
Radford, J., 1 Jun 2024, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 42, 16, p. 1868-1870 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study
Hamadani, M., Caimi, P. F., Hess, B., Radford, J., Solh, M., Zinzani, P. L., Wang, L., Xu, Z. C. & Carlo-Stella, C., 2024, (Accepted/In press) In: Future Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
Luminari, S., Fossa, A., Trotman, J., Molin, D., d'Amore, F., Enblad, G., Berkahn, L., Barrington, S. F., Radford, J., Federico, M., Kirkwood, A. A. & Johnson, P. W. M., 1 Jan 2024, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 42, 1, p. 13-18 6 p.Research output: Contribution to journal › Article › peer-review
Open Access
-
NIHR Manchester Biomedical Research Centre
Bruce, I. (PI), Lord, G. (CoI), Lennon, R. (CoI), Black, G. (CoI), Wedge, D. (CoI), Morris, A. (CoI), Hussell, T. (CoI), Sharrocks, A. (CoI), Stivaros, S. (CoI), Buch, M. (CoI), Gough, J. (CoI), Kostarelos, K. (CoI), Thistlethwaite, F. (CoI), Kadler, K. (CoI), Barton, A. (CoI), Hyrich, K. (CoI), Mcbeth, J. (CoI), O'Neill, T. (CoI), Vestbo, J. (CoI), Simpson, A. (CoI), Singh, S. (CoI), Smith, J. (CoI), Felton, T. (CoI), Murray, C. (CoI), Griffiths, C. (CoI), Cullum, N. (CoI), Rhodes, L. (CoI), Warren, R. (CoI), Paus, R. (CoI), Dumville, J. (CoI), Viros Usandizaga, A. (CoI), Keavney, B. (CoI), Tomaszewski, M. (CoI), Allan, S. (CoI), Body, R. (CoI), Cartwright, E. (CoI), Heagerty, A. (CoI), Kalra, P. (CoI), Miller, C. (CoI), Rutter, M. (CoI), Smith, C. (CoI), Trafford, A. (CoI), Evans, D. (CoI), Crosbie, E. (CoI), Crosbie, P. (CoI), Harvie, M. (CoI), Howell, S. (CoI), Renehan, A. (CoI), Dive, C. (CoI), Blackhall, F. (CoI), Landers, D. (CoI), Krebs, M. (CoI), Cook, N. (CoI), Clarke, R. (CoI), Taylor, S. (CoI), Jorgensen, C. (CoI), Lorigan, P. (CoI), Jayson, G. (CoI), Valle, J. (CoI), Mccabe, M. (CoI), Armstrong, A. (CoI), Freitas, A. (CoI), Illidge, T. (CoI), Choudhury, A. (CoI), Hoskin, P. (CoI), West, C. (CoI), Van Herk, M. (CoI), Faivre-Finn, C. (CoI), Bristow, R. (CoI), Kirkby, K. (CoI), Birtle, A. (CoI), Mackay, R. (CoI), Radford, J. (CoI), Linton, K. (CoI), Higham, C. (CoI), Munro, K. (CoI), Plack, C. (CoI), Arden Armitage, C. (CoI), Bruce, I. (CoI), Moore, D. (CoI), Saunders, G. (CoI), Stone, M. (CoI), Haddock, G. (CoI), Lewis, S. (CoI), Elliott, R. (CoI), Green, J. (CoI), Lovell, K. (CoI), Morrison, A. (CoI), Shaw, J. (CoI), Bucci, S. (CoI), Ainsworth, J. (CoI), Webb, R. (CoI), Newman, W. (CoI), Banka, S. (CoI), Clayton-Smith, J. (CoI), Payne, K. (CoI), Moldovan, R. (CoI), Wynn, R. (CoI) & Jones, S. (CoI)
1/12/22 → 30/11/27
Project: Research
-
NIHR Biomedical Research Centre: Cancer Precision Medicine Theme.
Dive, C. (PI), Baena Chaparro, E. (CoI), Blackhall, F. (CoI), Bruce, I. (CoI), Bundred, N. (CoI), Carter, L. (CoI), Clarke, R. (CoI), Cook, N. (CoI), Crosbie, P. (CoI), Evans, D. (CoI), Harris, J. (CoI), Hawkins, R. (CoI), Hussell, T. (CoI), Illidge, T. (CoI), Jayson, G. (CoI), Jorgensen, C. (CoI), Kirwan, C. (CoI), Kostarelos, K. (CoI), Krebs, M. (CoI), Lorigan, P. (CoI), Marais, R. (CoI), Marshall, K. (CoI), Metcalf, R. (CoI), Payne, K. (CoI), Radford, J. (CoI), Somervaille, T. (CoI), Springer, C. (CoI), Taylor, S. (CoI), Thistlethwaite, F. (CoI), Viros Usandizaga, A. (CoI) & Zelenay, S. (CoI)
1/04/17 → 31/03/19
Project: Research
-
Manchester Molecular Pathology Innovation Centre (MMPathIC): Bridging the Gap Between Biomarker Discovery and Health and Wealth.
Freemont, A. (PI), Ananiadou, S. (CoI), Barton, A. (CoI), Black, G. (CoI), Bruce, I. (CoI), Buchan, I. (CoI), Byers, R. (CoI), Dive, C. (CoI), Goodacre, R. (CoI), Griffiths, C. (CoI), Hoyland, J. (CoI), Payne, K. (CoI), Radford, J. (CoI) & Whetton, A. (CoI)
1/10/15 → 31/03/21
Project: Research
Prizes
-
Outstanding Contribution To Society Through Research
Howell, S. (Recipient) & Radford, J. (Recipient), 2023
Prize: Prize (including medals and awards)
Impacts
-
Access to more effective therapies in Non-Hodgkin Lymphoma
Illidge, T. (Corresponding participant), Radford, J. (Participant) & Honeychurch, J. (Participant)
Impact: Health and wellbeing, Economic
-
Improving survival and reducing treatment damage in Hodgkin lymphoma.
Radford, J. (Corresponding participant) & Illidge, T. (Participant)
Impact: Health and wellbeing
-
Working towards a national lung cancer screening programme in very high risk Hodgkin lymphoma (HL) survivors to improve prevention and early detection
Linton, K. (Corresponding participant), Radford, J. (Participant), Broadbent, R. (Participant), Arden Armitage, C. (Participant), Crosbie, P. (Participant) & Seale, T. (Participant)
Impact: Health and wellbeing